Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis
AbstractMagnetic resonance imaging (MRI) is an essential tool for the diagnosis of atherosclerosis, a chronic cardiovascular disease. MRI primarily uses superparamagnetic iron oxide (SPIO) as a contrast agent. However, SPIO integrated with therapeutic drugs has rarely been studied. In this study, we...
Main Authors: | Shuihua Zhang, Wan Xu, Peng Gao, Wenli Chen, Quan Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Artificial Cells, Nanomedicine, and Biotechnology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21691401.2019.1699823 |
Similar Items
-
Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy
by: Wei Li, et al.
Published: (2020-12-01) -
Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies
by: Sara Sánchez-Molina, et al.
Published: (2022-11-01) -
Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
by: Xue Li, et al.
Published: (2022-10-01) -
Therapy of rheumatoid arthritis by reactive oxygen species-responsive celastrol-loaded nanomedicines via targeting macrophages apoptosis
by: Sen Lin, et al.
Published: (2022-12-01) -
Recombinant Zea mays profilin forms multimers with pan-allergenic potential
by: Telly Psaradellis, et al.
Published: (2000-01-01)